In vitro activity of β-lactams in combination with avibactam against multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Achromobacter xylosoxidans isolates from patients with cystic fibrosis-Reference-Cited by-同舟云学术

In vitro activity of β-lactams in combination with avibactam against multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Achromobacter xylosoxidans isolates from patients with cystic fibrosis

Published:2018-09-01 Issue:9 Volume:67 Page:1217-1220
ISSN:0022-2615
Container-title:Journal of Medical Microbiology
language:en
Short-container-title:

Author:

Mathy Vincent¹,Grohs Patrick¹,Compain Fabrice¹²

Affiliation:

1. 1Department of Microbiology, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France

2. 2INSERM UMRS 1138, Sorbonne Universités, UPMC Univ Paris 06; Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot; Centre de Recherche des Cordeliers, 75006 Paris, France

Publisher

Microbiology Society

Subject

Microbiology (medical),General Medicine,Microbiology

Reference24 articles.

1. Cystic fibrosis

2. Cystic Fibrosis Pulmonary Guidelines

3. Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients

4. ECFS best practice guidelines: the 2018 revision

5. Prevalence and Outcomes of Achromobacter Species Infections in Adults with Cystic Fibrosis: a North American Cohort Study

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multicenter evaluation of activity of aztreonam in combination with avibactam, relebactam, and vaborbactam against metallo-β-lactamase-producing carbapenem-resistant gram-negative bacilli;Antimicrobial Agents and Chemotherapy;2024-08-19

2. Clinical and microbiological features of positive blood culture episodes caused by non-fermenting gram-negative bacilli other than Pseudomonas and Acinetobacter species (2020–2023);Infection;2024-07-11

3. Colistin the last resort drug in 21st century antibiotics to combat Multidrug resistance superbugs;Journal of Experimental Biology and Agricultural Sciences;2023-12-31

4. A Review of the Resistance Mechanisms for β-Lactams, Macrolides and Fluoroquinolones among Streptococcus pneumoniae;Medicina;2023-10-31

5. Comparative in vitro activities of eravacycline in combination with colistin, meropenem, or ceftazidime against various Achromobacter spp. strains isolated from patients with cystic fibrosis;Journal of Chemotherapy;2023-05-21